Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease

Lin Huang,1 Ke-Liang Chen,1 Bi-Ying Lin,1 Le Tang,1 Qian-Hua Zhao,1 Ying-Ru Lv,2,* Qi-Hao Guo1,* 1Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China; 2Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China *These authors con...

Full description

Bibliographic Details
Main Authors:	Huang L, Chen KL, Lin BY, Tang L, Zhao QH, Lv YR, Guo QH
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-08-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	Mild Cognitive Impairment Montreal Cognitive Assessment Alzheimer's Disease cut-off study.
Online Access:	https://www.dovepress.com/chinese-version-of-montreal-cognitive-assessment-basic-for-discriminat-peer-reviewed-article-NDT

Similar Items

The items in the Chinese version of the Montreal cognitive assessment basic discriminate among different severities of Alzheimer’s disease
by: Yan-Rong Zhang, et al.
Published: (2019-11-01)

Optimal Cutoff Scores for Dementia and Mild Cognitive Impairment in the Brazilian Version of the Montreal Cognitive Assessment among the Elderly
by: Tiago C.C. Pinto, et al.
Published: (2019-02-01)

Psychometric Properties of the Persian Montreal Cognitive Assessment in Mild Cognitive Impairment and Alzheimer Disease
by: Vahid Rashedi, et al.
Published: (2021-03-01)

Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination
by: Krisly Arguedas Vásquez, et al.

Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose
by: Yeung PY, et al.
Published: (2020-11-01)

Neurocognition of Aged Patients With Chronic Tinnitus: Focus on Mild Cognitive Impairment
by: Sang-Yeon Lee, et al.
Published: (2020-02-01)

Psychometric Properties of the Montreal Cognitive Assessment (MoCA) in Parkinson's Disease Patients in Isfahan
by: Golita Emsaki, et al.
Published: (2011-12-01)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
by: Corinna M. Bauer, et al.
Published: (2018-02-01)

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
by: Wang J, et al.
Published: (2020-01-01)

The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores
by: Damian, Anne Mariam
Published: (2012)

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
by: Fulop T, et al.
Published: (2021-05-01)

Hippocampus, caudate nucleus and entorhinal cortex volumetric MRI measurements in discrimination between Alzheimer’s disease, mild cognitive impairment, and normal aging
by: Rasha Elshafey, et al.
Published: (2014-06-01)

Facial emotion mimicry in older adults with and without cognitive impairments due to Alzheimer's disease
by: Justyna Gerłowska, et al.
Published: (2021-01-01)

Comparison of performance on neuropsychological tests in amnestic Mild Cognitive Impairment and Alzheimer's disease patients
by: Patrícia Helena Figueirêdo do Vale, et al.

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative
by: Russo MJ, et al.
Published: (2016-09-01)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018-10-01)

Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version
by: Darshpreet Kaur, et al.
Published: (2013-01-01)

Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
by: Sebastian Bello-Lepe, et al.
Published: (2020-10-01)

Language in Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type: Quantitatively or Qualitatively Different?
by: Regina Jokel, et al.
Published: (2019-03-01)

Screening for Very Mild Subcortical Vascular Dementia Patients Aged 75 and Above Using the Montreal Cognitive Assessment and Mini-Mental State Examination in a Community: The Kurihara Project
by: Mari Kasai, et al.
Published: (2012-11-01)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
by: Patrícia Helena Figueirêdo Vale Capucho, et al.

Detection and recognition thresholds for five basic tastes in patients with mild cognitive impairment and Alzheimer’s disease dementia
by: Minoru Kouzuki, et al.
Published: (2020-03-01)

A Comparison of Memory Beliefs, Cognitive Activity, and Depression Among Healthy Older Adults, Amnestic Mild Cognitive Impairment, and Patient with Alzheimer’s Disease
by: JongSik Park, et al.
Published: (2019-03-01)

Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer’s disease
by: Shuxia Qian, et al.
Published: (2021-04-01)

Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing
by: R. A. O’Neill, et al.
Published: (2021-03-01)

Evaluation of MoCA Scale Ratings with Cognitive Level Correlation in Mild Cognitive Disorders
by: Hatice Kübra Avcı Gülen, et al.
Published: (2017-03-01)

Probiotics for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
by: Guangsu Zhu, et al.
Published: (2021-07-01)

Role of DWI and MRS in diagnosis of Alzheimer’s and pre-Alzheimer’s disease
by: Amina Ahmed Sultan, MD, et al.
Published: (2017-03-01)

Alzheimer’s Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers
by: Shraddha Sapkota, et al.
Published: (2018-10-01)

Cognitive performance in patients with Mild Cognitive Impairment and Alzheimer's disease with white matter hyperintensities: An exploratory analysis
by: Maila Rossato Holz, et al.

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
by: Eric D. Anderson, et al.
Published: (2016-01-01)

Anesthesia and Alzheimer's: A review
by: Jeffrey Y Sun
Published: (2020-01-01)

An atlas on biomarkers for Alzheimer’s disease
by: Marta eMartínez-Rivera
Published: (2013-11-01)

A Longitudinal Study of Episodic and Semantic Autobiographical Memory in aMCI and Alzheimer’s Disease Patients
by: Juan C. Meléndez, et al.
Published: (2021-06-01)

Perceived caregiver stress in Alzheimer′s disease and mild cognitive impairment: A case control study
by: Kuljeet Singh Anand, et al.
Published: (2016-01-01)

Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease
by: Choe YM, et al.
Published: (2018-09-01)

Prediction of Driving Ability in Healthy Older Adults and Adults with Alzheimer’s Dementia or Mild Cognitive Impairment
by: Hoggarth, Petra Ann
Published: (2011)

Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
by: Joseph Giorgio, et al.
Published: (2020-01-01)

Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers
by: Elizabeth A. Wise, et al.
Published: (2019-12-01)

Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature
by: Alex Ward, et al.
Published: (2013-09-01)